홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Bromocrotonic acid → 7-[(2E)-4-(1,4-Oxazepan-4-yl)but-2-enoyl]-N-[1-(pyridin-2-ylmethyl)-1H-indazol-5-yl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine

HRID 38599
인쇄

반응식

HRID 38599 반응식
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[CH2:7][N:8]1[C:16]2[C:11](=[CH:12][C:13]([NH:17][C:18]3[C:19]4[C:26]5[CH2:27][CH2:28][NH:29][CH2:30][C:25]=5[S:24][C:20]=4[N:21]=[CH:22][N:23]=3)=[CH:14][CH:15]=2)[CH:10]=[N:9]1.Br[CH2:32]/[CH:33]=[CH:34]/[C:35]([OH:37])=O.Cl.[O:39]1[CH2:45][CH2:44][CH2:43][NH:42][CH2:41][CH2:40]1>>[O:39]1[CH2:45][CH2:44][CH2:43][N:42]([CH2:32]/[CH:33]=[CH:34]/[C:35]([N:29]2[CH2:28][CH2:27][C:26]3[C:19]4[C:18]([NH:17][C:13]5[CH:12]=[C:11]6[C:16](=[CH:15][CH:14]=5)[N:8]([CH2:7][C:2]5[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=5)[N:9]=[CH:10]6)=[N:23][CH:22]=[N:21][C:20]=4[S:24][C:25]=3[CH2:30]2)=[O:37])[CH2:41][CH2:40]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 64364114-Bromocrotonic acidHCID 230902141,4-Oxazepane hydrochlorideHCID 58116989N-[1-(Pyridin-2-ylmethyl)-1H-indazol-5-yl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]-pyrimidin-4-amine

생성물 1

HCID 581168517-[(2E)-4-(1,4-Oxazepan-4-yl)but-2-enoyl]-N-[1-(pyridin-2-ylmethyl)-1H-indazol-5-yl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine

실험 절차

The title compound was synthesized in analogy to Example 130 from N-[1-(pyridin-2-ylmethyl)-1H-indazol-5-yl]-5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-4-amine from Example 62A (100 mg, 0.24 mmol), (2E)-4-bromobut-2-enoic acid (75 mg, 0.36 mmol) and 1,4-oxazepane hydrochloride (53 mg, 0.39 mmol) to yield 62 mg (42%).

후처리

  1. customto yield 62 mg (42%)

출처 및 근거

ORD 기록
ord-2de62650b62f44719b85b8618e0f7ac0
출처 데이터셋
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08524722B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트